{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:27:04Z","timestamp":1783348024404,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Early scientific training program of Anhui Medical University","award":["2022-ZQKY-194"],"award-info":[{"award-number":["2022-ZQKY-194"]}]},{"name":"College Students\u2019 Innovation and Entrepreneurship Training Program of Anhui Medical University","award":["X202310366062"],"award-info":[{"award-number":["X202310366062"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1245\/s10434-026-19698-8","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:37:00Z","timestamp":1776778620000},"page":"7778-7789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the Associations and Mechanisms Between Antihypertensive Drugs and Urological Tumors: Insights from a Mendelian Randomization Study"],"prefix":"10.1245","volume":"33","author":[{"given":"Kun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiding","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"1","key":"19698_CR1","first-page":"60","volume":"8","author":"H Zi","year":"2021","unstructured":"Zi H, He S-H, Leng X-Y, Xu X-F, Huang Q, Weng H, et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990\u20132019. Mil Med Res. 2021;8(1):60.","journal-title":"Mil Med Res."},{"issue":"5","key":"19698_CR2","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jso.27031","volume":"126","author":"H Herr","year":"2022","unstructured":"Herr H, Sogani P, Eastham J. Genitourinary tumors. J Surg Oncol. 2022;126(5):926\u201332.","journal-title":"J Surg Oncol."},{"issue":"4","key":"19698_CR3","first-page":"1005","volume":"11","author":"E Stikbakke","year":"2022","unstructured":"Stikbakke E, Schirmer H, Knutsen T, St\u00f8yten M, Wilsgaard T, Giovannucci EL, et al. Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study Cancer Med. 2022;11(4):1005\u201315.","journal-title":"The PROCA-life study. Cancer Med."},{"issue":"6","key":"19698_CR4","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/healthcare10061074","volume":"10","author":"M Connaughton","year":"2022","unstructured":"Connaughton M, Dabagh M. Association of Hypertension and Organ-Specific Cancer: A Meta-Analysis. Healthcare (Basel). 2022;10(6):1074.","journal-title":"Healthcare (Basel)."},{"issue":"5","key":"19698_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.2174\/1567201820666230623121433","volume":"21","author":"N Fatima","year":"2024","unstructured":"Fatima N, Ashique S, Upadhyay A, Kumar S, Kumar H, Kumar N, et al. Current Landscape of Therapeutics for the Management of Hypertension - A Review. Curr Drug Deliv. 2024;21(5):662\u201382.","journal-title":"Curr Drug Deliv."},{"issue":"1","key":"19698_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/pros.10294","volume":"58","author":"G Ronquist","year":"2004","unstructured":"Ronquist G, Rodr\u00edguez LAG, Ruig\u00f3mez A, Johansson S, Wallander M-A, Frithz G, et al. Association between captopril, other antihypertensive drugs and risk of prostate cancer. Prostate. 2004;58(1):50\u20136.","journal-title":"Prostate."},{"issue":"5\u20136","key":"19698_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/21681805.2018.1559882","volume":"52","author":"A Siltari","year":"2018","unstructured":"Siltari A, Murtola TJ, Talala K, Taari K, Tammela TLJ, Auvinen A. Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort. Scand J Urol. 2018;52(5\u20136):321\u20137.","journal-title":"Scand J Urol."},{"issue":"2","key":"19698_CR8","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.18632\/aging.102699","volume":"12","author":"Y Xie","year":"2020","unstructured":"Xie Y, Xu P, Wang M, Zheng Y, Tian T, Yang S, et al. Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis. Aging (Albany NY). 2020;12(2):1545\u201362.","journal-title":"Aging (Albany NY)."},{"issue":"2","key":"19698_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/CEJ.0000000000000419","volume":"28","author":"V Guercio","year":"2019","unstructured":"Guercio V, Turati F, Bosetti C, Polesel J, Serraino D, Montella M, et al. Bladder cancer risk in users of selected drugs for cardiovascular disease prevention. Eur J Cancer Prev. 2019;28(2):76\u201380.","journal-title":"Eur J Cancer Prev."},{"issue":"4","key":"19698_CR10","first-page":"327","volume":"4","author":"WH Chow","year":"1995","unstructured":"Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni JF. Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension. Cancer Epidemiol Biomarkers Prev. 1995;4(4):327\u201331.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"19698_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.","journal-title":"BMJ."},{"issue":"11","key":"19698_CR12","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian Randomization as an Approach to Assess Causality Using Observational Data. J Am Soc Nephrol. 2016;27(11):3253\u201365.","journal-title":"J Am Soc Nephrol."},{"key":"19698_CR13","doi-asserted-by":"crossref","unstructured":"Ference BA, Holmes MV, Smith GD. Using Mendelian Randomization to Improve the Design of Randomized Trials. Cold Spring Harb Perspect Med. 2021;11 (7).","DOI":"10.1101\/cshperspect.a040980"},{"issue":"6","key":"19698_CR14","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ije\/dyx207","volume":"46","author":"VM Walker","year":"2017","unstructured":"Walker VM, Davey Smith G, Davies NM, Martin RM. Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities. Int J Epidemiol. 2017;46(6):2078\u201389.","journal-title":"Int J Epidemiol."},{"issue":"1","key":"19698_CR15","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt AF, Finan C, Gordillo-Mara\u00f1\u00f3n M, Asselbergs FW, Freitag DF, Patel RS, et al. Genetic drug target validation using Mendelian randomisation. Nat Commun. 2020;11(1):3255.","journal-title":"Nat Commun."},{"key":"19698_CR16","doi-asserted-by":"crossref","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46 (D1):D1074-D82.","DOI":"10.1093\/nar\/gkx1037"},{"issue":"10","key":"19698_CR17","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","volume":"50","author":"E Evangelou","year":"2018","unstructured":"Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018;50(10):1412\u201325.","journal-title":"Nat Genet."},{"issue":"7944","key":"19698_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature."},{"issue":"7","key":"19698_CR19","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018;50(7):928\u201336.","journal-title":"Nat Genet."},{"issue":"9","key":"19698_CR20","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310.","journal-title":"Nat Genet."},{"issue":"1","key":"19698_CR21","doi-asserted-by":"publisher","DOI":"10.71321\/ktnt2936","volume":"1","author":"Y Liu","year":"2024","unstructured":"Liu Y, Liu R, Zhao Y, Wang Y, Hou X, Cao F, Fan X, Xing L, An B, Tian F. A Mendelian randomization study investigating the causal relationship between 35 blood and urine metabolite biomarkers and postmenopausal osteoporosis. Life Conflux. 2024;1(1):e111.","journal-title":"Life Conflux."},{"issue":"5","key":"19698_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481\u20137.","journal-title":"Nat Genet."},{"issue":"5","key":"19698_CR23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","volume":"109","author":"V Zuber","year":"2022","unstructured":"Zuber V, Grinberg NF, Gill D, Manipur I, Slob EAW, Patel A, et al. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches. Am J Hum Genet. 2022;109(5):767\u201382.","journal-title":"Am J Hum Genet."},{"issue":"1","key":"19698_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12933-022-01613-6","volume":"21","author":"K Wang","year":"2022","unstructured":"Wang K, Shi M, Huang C, Fan B, Luk AOY, Kong APS, et al. Evaluating the impact of glucokinase activation on risk of cardiovascular disease: a Mendelian randomisation analysis. Cardiovasc Diabetol. 2022;21(1):192.","journal-title":"Cardiovasc Diabetol."},{"issue":"6","key":"19698_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jamapsychiatry.2021.0005","volume":"78","author":"S Chauquet","year":"2021","unstructured":"Chauquet S, Zhu Z, O\u2019Donovan MC, Walters JTR, Wray NR, Shah S. Association of Antihypertensive Drug Target Genes With Psychiatric Disorders: A Mendelian Randomization Study. JAMA Psychiatry. 2021;78(6):623\u201331.","journal-title":"JAMA Psychiatry."},{"issue":"3","key":"19698_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jclinepi.2014.09.005","volume":"68","author":"JF Cohen","year":"2014","unstructured":"Cohen JF, Chalumeau M, Cohen R, Korevaar DA, Khoshnood B, Bossuyt PMM. Cochran\u2019s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy. J Clin Epidemiol. 2014;68(3):299\u2013306.","journal-title":"J Clin Epidemiol."},{"issue":"6","key":"19698_CR27","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-022-01539-0","volume":"41","author":"DC Mitchell","year":"2023","unstructured":"Mitchell DC, Kuljanin M, Li J, Van Vranken JG, Bulloch N, Schweppe DK, et al. A proteome-wide atlas of drug mechanism of action. Nat Biotechnol. 2023;41(6):845\u201357.","journal-title":"Nat Biotechnol."},{"key":"19698_CR28","doi-asserted-by":"crossref","unstructured":"Snaebjarnarson AS, Helgadottir A, Arnadottir GA, Ivarsdottir EV, Thorleifsson G, Ferkingstad E, et al. Complex effects of sequence variants on lipid levels and coronary artery disease. Cell. 2023;186 (19).","DOI":"10.1016\/j.cell.2023.08.012"},{"issue":"3","key":"19698_CR29","first-page":"314","volume":"11","author":"RC Zink","year":"2013","unstructured":"Zink RC, Huang Q, Zhang L-Y, Bao W-J. Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance. Chin J Nat Med. 2013;11(3):314\u201320.","journal-title":"Chin J Nat Med."},{"issue":"11","key":"19698_CR30","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.joca.2022.06.010","volume":"30","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li D, Zhu Z, Chen S, Lu M, Cao P, et al. Evaluating the impact of metformin targets on the risk of osteoarthritis: a mendelian randomization study. Osteoarthritis Cartilage. 2022;30(11):1506\u201314.","journal-title":"Osteoarthritis Cartilage."},{"issue":"2","key":"19698_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/03009734.2018.1473534","volume":"123","author":"VC Kok","year":"2018","unstructured":"Kok VC, Zhang H-W, Lin C-T, Huang S-C, Wu M-F. Positive association between hypertension and urinary bladder cancer: epidemiologic evidence involving 79,236 propensity score-matched individuals. Ups J Med Sci. 2018;123(2):109\u201315.","journal-title":"Ups J Med Sci."},{"issue":"7","key":"19698_CR32","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/HJH.0000000000001286","volume":"35","author":"K Hidayat","year":"2017","unstructured":"Hidayat K, Du X, Zou S-Y, Shi B-M. Blood pressure and kidney cancer risk: meta-analysis of prospective studies. J Hypertens. 2017;35(7):1333\u201344.","journal-title":"J Hypertens."},{"issue":"3","key":"19698_CR33","first-page":"463","volume":"21","author":"RM Martin","year":"2010","unstructured":"Martin RM, Vatten L, Gunnell D, Romundstad P. Blood pressure and risk of prostate cancer: Cohort Norway (CONOR). Cancer Causes Control. 2010;21(3):463\u201372.","journal-title":"Cancer Causes Control."},{"key":"19698_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120218","volume":"289","author":"SE Abu-Risha","year":"2022","unstructured":"Abu-Risha SE, Mousa MA, Elsisi AE. Protective role of irbesartan against cyclophosphamide-induced testicular damage in rats via up-regulating PPAR-\u03b3 signaling and ameliorating NF-\u03baB\/NLRP3\/IL-18 inflammatory axis. Life Sci. 2022;289:120218.","journal-title":"Life Sci."},{"issue":"2","key":"19698_CR35","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s11033-019-05196-6","volume":"47","author":"G Wang","year":"2020","unstructured":"Wang G, Cheng S, Zhang S, Zhu Y, Xiao Y, Ju L. LPS impairs steroidogenesis and ROS metabolism and induces PPAR transcriptional activity to disturb estrogen\/androgen receptor expression in testicular cells. Mol Biol Rep. 2020;47(2):1045\u201356.","journal-title":"Mol Biol Rep."},{"key":"19698_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103214","volume":"146","author":"Q Geng","year":"2024","unstructured":"Geng Q, Xu J, Cao X, Wang Z, Jiao Y, Diao W, et al. PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis. J Autoimmun. 2024;146:103214.","journal-title":"J Autoimmun."},{"issue":"4","key":"19698_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","volume":"47","author":"BM Spiegelman","year":"1998","unstructured":"Spiegelman BM. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes. 1998;47(4):507\u201314.","journal-title":"Diabetes."},{"issue":"2","key":"19698_CR38","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1006\/bbrc.2000.2436","volume":"270","author":"Y Tsubouchi","year":"2000","unstructured":"Tsubouchi Y, Sano H, Kawahito Y, Mukai S, Yamada R, Kohno M, et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun. 2000;270(2):400\u20135.","journal-title":"Biochem Biophys Res Commun."},{"issue":"1","key":"19698_CR39","doi-asserted-by":"publisher","first-page":"220","DOI":"10.2174\/156652413804486205","volume":"13","author":"PC Chen","year":"2013","unstructured":"Chen PC, Li C, Wang D, Luo ZW, Fu SJ, Li X, et al. PP-1\u03b1 and PP-1\u03b3 display antagonism and differential roles in tumorigenicity of lung cancer cells. Curr Mol Med. 2013;13(1):220\u20137.","journal-title":"Curr Mol Med."},{"key":"19698_CR40","doi-asserted-by":"crossref","unstructured":"Chen BY-H, Huang C-H, Lin Y-H, Huang C-C, Deng C-X, Hsu L-C. The K898E germline variant in the PP1-binding motif of BRCA1 causes defects in DNA Repair. Sci Rep. 2014;4:5812.","DOI":"10.1038\/srep05812"},{"issue":"5","key":"19698_CR41","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013404","volume":"13","author":"Y Lin","year":"2021","unstructured":"Lin Y, Cui C, Su M, Silbart LK, Liu H, Zhao J, et al. Identification of TAPBPL as a novel negative regulator of T-cell function. EMBO Mol Med. 2021;13(5):e13404.","journal-title":"EMBO Mol Med."},{"issue":"9123","key":"19698_CR42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0140-6736(98)03228-0","volume":"352","author":"AF Lever","year":"1998","unstructured":"Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet. 1998;352(9123):179\u201384.","journal-title":"Lancet."},{"issue":"11","key":"19698_CR43","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/sj.bjc.6605955","volume":"103","author":"Y Nakai","year":"2010","unstructured":"Nakai Y, Isayama H, Ijichi H, Sasaki T, Sasahira N, Hirano K, et al. Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. Br J Cancer. 2010;103(11):1644\u20138.","journal-title":"Br J Cancer."},{"issue":"23","key":"19698_CR44","doi-asserted-by":"publisher","first-page":"35224","DOI":"10.18632\/oncotarget.9109","volume":"7","author":"H Nakagawa","year":"2016","unstructured":"Nakagawa H, Ueda T, Ito S, Shiraishi T, Taniguchi H, Kayukawa N, et al. Androgen suppresses testicular cancer cell growth in vitro and in vivo. Oncotarget. 2016;7(23):35224\u201332.","journal-title":"Oncotarget."},{"issue":"12","key":"19698_CR45","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.21873\/anticanres.16766","volume":"43","author":"A Maeda-Minami","year":"2023","unstructured":"Maeda-Minami A, Nishikawa T, Ishikawa H, Mutoh M, Makishima Y, Matsuyama Y, et al. Angiotensin II Receptor Blockers Cause Changes in Prostate-specific Antigen Levels: A Retrospective Cohort Study. Anticancer Res. 2023;43(12):5629\u201336.","journal-title":"Anticancer Res."},{"issue":"11","key":"19698_CR46","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrc2945","volume":"10","author":"AJ George","year":"2010","unstructured":"George AJ, Thomas WG, Hannan RD. The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer. 2010;10(11):745\u201359.","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"19698_CR47","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1038\/s41598-025-90734-5","volume":"15","author":"H Hashimoto","year":"2025","unstructured":"Hashimoto H, Nojiri S, Takeda T, Urasaki W, Nishizaki Y, Nagahara A, et al. Examining associations of digestive system cancer with hypertension and diabetes using network analysis in older patients. Sci Rep. 2025;15(1):6458.","journal-title":"Sci Rep."},{"issue":"10","key":"19698_CR48","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41419-018-1100-1","volume":"9","author":"Y-P Lv","year":"2018","unstructured":"Lv Y-P, Peng L-S, Wang Q-H, Chen N, Teng Y-S, Wang T-T, et al. Degranulation of mast cells induced by gastric cancer-derived adrenomedullin prompts gastric cancer progression. Cell Death Dis. 2018;9(10):1034.","journal-title":"Cell Death Dis."},{"issue":"11","key":"19698_CR49","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s40520-023-02530-8","volume":"35","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang Y, Zhao C, Cai W, Wang Z, Zhao W. Effects of blood pressure and antihypertensive drugs on osteoarthritis: a mendelian randomized study. Aging Clin Exp Res. 2023;35(11):2437\u201344.","journal-title":"Aging Clin Exp Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19698-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:08:41Z","timestamp":1783346921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19698-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["19698"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19698-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}